The role of RYK and Eph receptors in developmental and tumour angiogenesis
The role of RYK and Eph receptors in developmental and tumour angiogenesis
批准号:
nhmrc : 164801
负责人:
Prof Christopher Hovens
金额:
$13.1万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2001
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2001-01-01 至 2003-12-31
中文摘要
血管的形成(血管生成)是胚胎发育、伤口愈合、肿瘤形成-转移和缺血肢体血管重建的关键过程。控制这一过程的分子正在慢慢地被描述出来。一般都属于一类叫做生长因子的分子及其相关受体存在于细胞表面。这些分子可以控制体内特定血管的数量、位置和功能。最近,我们发现了一个叫做血管内皮生长因子的生长因子家族的新成员,并证明了它们促进血液和淋巴管生长的能力。在这项研究中,我们开始研究另一个生长因子受体家族,称为RYK(我们在美国和澳大利亚获得了专利)在血管生成中的作用。小鼠功能实验表明,RYK可以与Eph受体家族相关,Eph受体在血管发育和损伤期间的重塑中起关键作用。研究这些分子可以告诉我们,为什么血管知道在身体的正确位置,为什么在某些疾病中,我们看到的血管结构或位置不正确。这些研究将形成知识的基础,开发合理的手段来操纵血管的形成在体内,使用非手术的方法。这项工作也将应用于腭裂、颅面异常和轴突寻路等领域。
英文摘要
The formation of blood vessels (angiogenesis) is a key process in development of the embryo, wound healing, tumour formation-metastases and in the re-vascularisation of ischeamic limbs. The molecules which control these processess are slowly being characterised. In general belong to a family of molecules called growth factors and theri associated receptor present on the surface of a cell. These molecules can control the number, location and function of specific blood vessels within the body. Recently we have discoverd new members of a family of growth fcators called vascular endothelial growth factors, and demonstrated their ability to promote the growth of blood and lymphatic vessels. In this study we set out to examine the role of another family of growth factor receptors, called RYK (for which we have a granted patent in the USA and Australia) in angiogenesis. functional experiments in mice have demonstrated that RYK can associated with a family of receptors called Eph receptors which play a key role in the remodelling of blood vessels during development and injury. Studying these molecules may tell us why blood vessels know' to be in the correct locations in the body and why in certain disease we see vessels of incorrect structure or location. These studies will form a basis of knowledge to develop rational means to manipulate blood vessel formation in the body, using non-surgical methods. The work will also have application to the areas of cleft palate, craniofacial abnormalities and axon pathfinding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Ryk/AF6/Eph complexes in neuronal pathfinding/fasciculation
-
批准号:nhmrc : 145770
-
项目类别:NHMRC Project Grants
-
资助金额:$28.14万
-
财政年份:2001
-
负责人:Prof Christopher Hovens
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向Wnt5a/Ryk调控TRPV1介导的外周敏化防治骨癌痛的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:翟明珠
-
依托单位:
Wnt5a/Ryk信号通路参与放射治疗后颈动脉粥样硬化进展的关键调控机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:曹勇军
-
依托单位:
Smek蛋白调控Wnt/Ryk信号通路影响胎鼠大脑皮层早期发育的分子机制
-
批准号:81270700
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:韩平
-
依托单位:
Wnt/Ryk信号通路介导的神经定向芽生对根性痛的作用和机制研究
-
批准号:81271236
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:欧阳跃平
-
依托单位:
Wnt与Ryk受体在缝核脊髓神经通路发育中的神经导向作用
-
批准号:30771063
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:刘耀波
-
依托单位:
Wnt蛋白及Ryk受体在脊髓神经再生中的作用研究
-
批准号:30640006
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2006
-
负责人:刘耀波
-
依托单位: